RxDoctor Payments Data

Rohit Bawa, MD

Otolaryngology · Richmond, INNPI 1700888955

Payments from drug & device makers

What this record shows

Stryker accounts for 88.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $1,767 and has fallen 91.5% since, to $150 in 2025.

$2,844in general payments, 2019–2025

Across 42 payments — averaging $67.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Sanofi$140
  • Aerin Medical Inc.$112
  • AstraZeneca$26
  • Regeneron Healthcare Solutions, Inc.$20
  • Merck$18
  • plus $16 from 1 others

What the payments were for

  • Travel & lodging$1,25944%
  • Food & beverage$1,58556%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,844 in reported general payments places this provider in the 70th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$228,048
Medicare patients
659
Services billed
1,501

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl158$4,787
Ipratropium Bromide138$4,547
Fluticasone Propionate283$3,414
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort32$1,736
Omeprazole229$1,731
Levothyroxine Sodium234$1,082
CefuroximeCefuroxime Axetil60$1,015
Tobramycin-DexamethasoneTobramycin/Dexamethasone12$998
Nystatin36$622
Clotrimazole14$524
Methylprednisolone85$478
Ofloxacin23$413
Montelukast Sodium36$401
Famotidine42$395
SynthroidLevothyroxine Sodium21$338

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Richmond

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →